Translational research in infectious disease: Current paradigms and challenges ahead

Translational Research

Volumn 159, Issue 6, 2012, Pages 430-453

  Fontana, Judith M ^a   Alexander, Elizabeth ^a   Salvatore, Mirella ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

CLINICAL PRACTICE; COST; DNA SEQUENCE; DRUG DEVELOPMENT; EPSTEIN BARR VIRUS; FUNCTIONAL PROTEOMICS; GENOMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; INFECTION; METABOLOMICS; MICROARRAY ANALYSIS; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SALMONELLA ENTERICA; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STRUCTURAL PROTEOMICS; SYSTEMS BIOLOGY; TANDEM MASS SPECTROMETRY; TRANSLATIONAL RESEARCH; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; TWO DIMENSIONAL ELECTROPHORESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VACCINATION; VIRUS INFECTION; YERSINIA PESTIS;

EID: 84861646217     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2011.12.009     Document Type: Review

References (250)

1. [No authors listed] Lost in clinical translation Nat Med 10 2004 879
2. S.H. Woolf The meaning of translational research and why it matters JAMA 299 2008 211 213
3. National Center for Research Resources. Clinical and Translational Science Awards. 2011.
4. National Institutes of Health National Center for Research Resources 2011 NIH Bethesda, Md
5. S.J. Steele Working with the CTSA Consortium: what we bring to the table Sci Transl Med 2 2010 63mr5
6. K.J. Pienta, A.L. Spork, and J. Scheske The Clinical and Translational Science Awards (CTSAs) are transforming the way academic medical institutions approach translational research: the University of Michigan Experience Clin Transl Sci 4 2011 233 235
7. C. Schubert Four years on, clinical partnerships program proves worth Nat Med 16 2010 612 613
8. F.S. Collins Reengineering translational science: the time is right Sci Transl Med 3 2011 90cm17
9. P. Cuatrecasas Drug discovery in jeopardy J Clin Invest 116 2006 2837 2842
10. B. Spellberg, J.H. Powers, E.P. Brass, L.G. Miller, and J.E. Edwards Jr. Trends in antimicrobial drug development: implications for the future Clin Infect Dis 38 2004 1279 1286
11. G. Harris Federal research center will help develop medicines New York Times January 23, 2011 A1
12. Office of Inspector General The orphan drug act: implementation and impact 1983 Department of Health and Human Services Washington, DC 13
13. J.D. Watson, and R.M. Cook-Deegan Origins of the human genome project FASEB J 5 1991 8 11
14. Proteome Research: New Frontiers in Functional Genomics 1997 Springer Berlin, Germany
15. S.G. Oliver, M.K. Winson, D.B. Kell, and F. Baganz Systematic functional analysis of the yeast genome Trends Biotechnol 16 1998 373 378
16. C.A. Hutchison 3rd DNA sequencing: bench to bedside and beyond Nucleic Acids Res 35 2007 6227 6237
17. A.M. Maxam, and W. Gilbert A new method for sequencing DNA Proc Natl Acad Sci U S A 74 1977 560 564
18. F. Sanger, S. Nicklen, and A.R. Coulson DNA sequencing with chain-terminating inhibitors Proc Natl Acad Sci U S A 74 1977 5463 5467
19. R.M. Gulick Antiretroviral treatment 2010: progress and controversies J Acquir Immune Defic Syndr 55 2010 S43 S48
20. L. Deng, and H. Tang Hepatitis B virus drug resistance to current nucleos(t)ide analogs: mechanisms and mutation sites Hepatol Res 41 2011 1017 1024
21. C.L. Lin, and J.H. Kao The clinical implications of hepatitis B virus genotype: recent advances J Gastroenterol Hepatol 26 2011 123 130
22. P. Vivekanandan, and O.V. Singh Molecular methods in the diagnosis and management of chronic hepatitis B Expert Rev Mol Diagn 10 2010 921 935
23. N. Hiraga, M. Imamura, and H. Abe Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo Hepatology 54 2011 781 788
24. S. Susser, J. Vermehren, and N. Forestier Analysis of long-term persistence of resistance mutations within the hepatitis C virus NS3 protease after treatment with telaprevir or boceprevir J Clin Virol 52 2011 321 327
25. T.L. Kieffer, A.D. Kwong, and G.R. Picchio Viral resistance to specifically targeted antiviral therapies for hepatitis C (STAT-Cs) J Antimicrob Chemother 65 2010 202 212
26. H.R. Rosen Clinical practice. Chronic hepatitis C infection N Engl J Med 364 2011 2429 2438
27. S. Duan, D.A. Boltz, and J. Li Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis Antimicrob Agents Chemother 55 2011 4718 4727
28. S.Y. Tong, F. Dakh, and A.C. Hurt Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting PLoS One 6 2011 e21446
29. L. Wijaya, Y.Y. Chua, L. Cui, K. Chan, and B.H. Tan Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus Singapore Med J 52 2011 481 485
30. B. Grondahl, W. Puppe, and A. Hoppe Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study J Clin Microbiol 37 1999 1 7
31. M.C. Edwards, and R.A. Gibbs Multiplex PCR: advantages, development, and applications PCR Methods Appl 3 1994 S65 S75
32. M. Uttamchandani, J.L. Neo, B.N. Ong, and S. Moochhala Applications of microarrays in pathogen detection and biodefence Trends Biotechnol 27 2009 53 61
33. D. Wang, L. Coscoy, and M. Zylberberg Microarray-based detection and genotyping of viral pathogens Proc Natl Acad Sci U S A 99 2002 15687 15692
34. D. Wang, A. Urisman, and Y.T. Liu Viral discovery and sequence recovery using DNA microarrays PLoS Biol 1 2003 E2
35. G. Palacios, P.L. Quan, and O.J. Jabado Panmicrobial oligonucleotide array for diagnosis of infectious diseases Emerg Infect Dis 13 2007 73 81
36. N.G. Anderson, J.L. Gerin, and N.L. Anderson Global screening for human viral pathogens Emerg Infect Dis 9 2003 768 774
37. W.I. Lipkin Microbe hunting Microbiol Mol Biol Rev 74 2010 363 377
38. P.A. Rota, M.S. Oberste, and S.S. Monroe Characterization of a novel coronavirus associated with severe acute respiratory syndrome Science 300 2003 1394 1399
39. K.A. Mihindukulasuriya, G. Wu, J. St Leger, R.W. Nordhausen, and D. Wang Identification of a novel coronavirus from a beluga whale by using a panviral microarray J Virol 82 2008 5084 5088
40. A. Kistler, P.C. Avila, and S. Rouskin Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity J Infect Dis 196 2007 817 825
41. C.Y. Chiu, A.L. Greninger, and K. Kanada Identification of cardioviruses related to Theiler's murine encephalomyelitis virus in human infections Proc Natl Acad Sci U S A 105 2008 14124 14129
42. C. Connell, S. Fung, and C. Heiner Automated DNA-sequence analysis BioTechniques 5 1987 342 348
43. S. Brenner, M. Johnson, and J. Bridgham Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays Nat Biotechnol 18 2000 630 634
44. Stein RA. Next-generation sequencing update. Genetic Engineering & Biotechnology News 2008;28.
45. M. Margulies, M. Egholm, and W.E. Altman Genome sequencing in microfabricated high-density picolitre reactors Nature 437 2005 376 380
46. W.J. Ansorge Next-generation DNA sequencing techniques N Biotechnol 25 2009 195 203
47. S. Nakamura, C.S. Yang, and N. Sakon Direct metagenomic detection of viral pathogens in nasal and fecal specimens using an unbiased high-throughput sequencing approach PLoS One 4 2009 e4219
48. K. Sorber, C. Chiu, and D. Webster The long march: a sample preparation technique that enhances contig length and coverage by high-throughput short-read sequencing PLoS One 3 2008 e3495
49. J.M. Rothberg, and J.H. Leamon The development and impact of 454 sequencing Nat Biotechnol 26 2008 1117 1124
50. G. Palacios, J. Druce, and L. Du A new arenavirus in a cluster of fatal transplant-associated diseases N Engl J Med 358 2008 991 998
51. T. Briese, J.T. Paweska, and L.K. McMullan Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa PLoS Pathog 5 2009 e1000455
52. A.L. Greninger, C. Runckel, and C.Y. Chiu The complete genome of klassevirus - a novel picornavirus in pediatric stool Virol J 6 2009 82
53. H. Feng, M. Shuda, Y. Chang, and P.S. Moore Clonal integration of a polyomavirus in human Merkel cell carcinoma Science 319 2008 1096 1100
54. C.S. Chin, J. Sorenson, and J.B. Harris The origin of the Haitian cholera outbreak strain N Engl J Med 364 2011 33 42
55. R.J. Garten, C.T. Davis, and C.A. Russell Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans Science 325 2009 197 201
56. J.F. Bell, J.T. Wright, and K. Habel Rabies vaccine freed of the factor causing allergic encephalitis Proc Soc Exp Biol Med 70 1949 457 461
57. L.N. Alexander, J.F. Seward, and T.A. Santibanez Vaccine policy changes and epidemiology of poliomyelitis in the United States JAMA 292 2004 1696 1701
58. R. Rappuoli Reverse vaccinology, a genome-based approach to vaccine development Vaccine 19 2001 2688 2691
59. L. Danzig Reverse vaccinology-in search of a genome-derived meningococcal vaccine Vaccine 24 2006 11 12
60. R. Yogev, and T. Tan Meningococcal disease: the advances and challenges of meningococcal disease prevention Hum Vaccin 7 2011 828 837
61. M. Pizza, V. Scarlato, and V. Masignani Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing Science 287 2000 1816 1820
62. H. Tettelin, D. Medini, C. Donati, and V. Masignani Towards a universal group B Streptococcus vaccine using multistrain genome analysis Expert Rev Vaccines 5 2006 687 694
63. K. Subbarao, and J.M. Katz Influenza vaccines generated by reverse genetics Curr Top Microbiol Immunol 283 2004 313 342
64. J. Steel New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges BioDrugs 25 2011 285 298
65. V. Wacheck, A. Egorov, and F. Groiss A novel type of influenza vaccine: safety and immunogenicity of replication-deficient influenza virus created by deletion of the interferon antagonist NS1 J Infect Dis 201 2010 354 362
66. S.E. Emonet, S. Urata, and J.C. de la Torre Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies Virology 411 2011 416 425
67. J.P. McGettigan Experimental rabies vaccines for humans Expert Rev Vaccines 9 2010 1177 1186
68. T. Horimoto, and Y. Kawaoka Designing vaccines for pandemic influenza Curr Top Microbiol Immunol 333 2009 165 176
69. J.A. Richt, and A. Garcia-Sastre Attenuated influenza virus vaccines with modified NS1 proteins Curr Top Microbiol Immunol 333 2009 177 195
70. M. Bouloy, and R. Flick Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines Antiviral Res 84 2009 101 118
71. M.A. Billeter, H.Y. Naim, and S.A. Udem Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses Curr Top Microbiol Immunol 329 2009 129 162
72. S.J. Draper, and J.L. Heeney Viruses as vaccine vectors for infectious diseases and cancer Nat Rev Microbiol 8 2010 62 73
73. C.S. Rollier, A. Reyes-Sandoval, M.G. Cottingham, K. Ewer, and A.V. Hill Viral vectors as vaccine platforms: deployment in sight Curr Opin Immunol 23 2011 377 382
74. C. Sofer-Podesta, J. Ang, and N.R. Hackett Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge Infect Immun 77 2009 1561 1568
75. K. Kasuya, J.L. Boyer, and Y. Tan Passive immunotherapy for anthrax toxin mediated by an adenovirus expressing an anti-protective antigen single-chain antibody Mol Ther 11 2005 237 244
76. D. Sparkman Mass spectrometry desk reference 2nd ed. 2006 Global View Publishing Pittsburgh, Pa
77. R. Aebersold, and M. Mann Mass spectrometry-based proteomics Nature 422 2003 198 207
78. W.P. Blackstock, and M.P. Weir Proteomics: quantitative and physical mapping of cellular proteins Trends Biotechnol 17 1999 121 127
79. M.R. Roe, and T.J. Griffin Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes Proteomics 6 2006 4678 4687
80. I.A. Brewis, and P. Brennan Proteomics technologies for the global identification and quantification of proteins Adv Protein Chem Struct Biol 80 2010 1 44
81. L. Malmstrom, J. Malmstrom, and R. Aebersold Quantitative proteomics of microbes: principles and applications to virulence Proteomics 11 2011 2947 2956
82. A. Alban, S.O. David, and L. Bjorkesten A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard Proteomics 3 2003 36 44
83. L. Ly, and V.C. Wasinger Protein and peptide fractionation, enrichment and depletion: tools for the complex proteome Proteomics 11 2011 513 534
84. P.W. Carr, D.R. Stoll, and X. Wang Perspectives on recent advances in the speed of high-performance liquid chromatography Anal Chem 83 2011 1890 1900
85. A.J. Link, J. Eng, and D.M. Schieltz Direct analysis of protein complexes using mass spectrometry Nat Biotechnol 17 1999 676 682
86. J.K.M. Eng, A.L. McCormack, and J.R. Yates An approach to correlate tandem mass spectral data of peptides with amino acid sequences is a protein database J Am Soc Mass Spectrom 5 1994 976 989
87. B.K. Faherty, and S.A. Gerber MacroSEQUEST: efficient candidate-centric searching and high-resolution correlation analysis for large-scale proteomics data sets Anal Chem 82 2010 6821 6829
88. T. Frohlich, and G.J. Arnold Proteome research based on modern liquid chromatography-tandem mass spectrometry: separation, identification and quantification J Neural Transm 113 2006 973 994
89. S.H. Chiou, and C.Y. Wu Clinical proteomics: current status, challenges, and future perspectives Kaohsiung J Med Sci 27 2011 1 14
90. M.H. Elliott, D.S. Smith, C.E. Parker, and C. Borchers Current trends in quantitative proteomics J Mass Spectrom 44 2009 1637 1660
91. C. Vogel, and E.M. Marcotte Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data Nat Protoc 3 2008 1444 1451
92. R. Matthiesen, and A.S. Carvalho Methods and algorithms for relative quantitative proteomics by mass spectrometry Methods Mol Biol 593 2010 187 204
93. L.N. Mueller, O. Rinner, and A. Schmidt SuperHirn - a novel tool for high resolution LC-MS-based peptide/protein profiling Proteomics 7 2007 3470 3480
94. V. Lange, P. Picotti, B. Domon, and R. Aebersold Selected reaction monitoring for quantitative proteomics: a tutorial Mol Syst Biol 4 2008 222
95. M.A. Kuzyk, D. Smith, and J. Yang Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol Cell Proteomics 8 2009 1860 1877
96. E. Lasonder, Y. Ishihama, and J.S. Andersen Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry Nature 419 2002 537 542
97. L. Florens, M.P. Washburn, and J.D. Raine A proteomic view of the Plasmodium falciparum life cycle Nature 419 2002 520 526
98. K.Y. Rhee, H. Erdjument-Bromage, P. Tempst, and C.F. Nathan S-nitroso proteome of Mycobacterium tuberculosis: enzymes of intermediary metabolism and antioxidant defense Proc Natl Acad Sci U S A 102 2005 467 472
99. T.G. Popova, M.J. Turell, and V. Espina Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells PLoS One 5 2010 e13805
100. E.Y. Chan, W.J. Qian, and D.L. Diamond Quantitative analysis of human immunodeficiency virus type 1-infected CD4+ cell proteome: dysregulated cell cycle progression and nuclear transport coincide with robust virus production J Virol 81 2007 7571 7583
101. X. Feng, J. Zhang, W.N. Chen, and C.B. Ching Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis J Proteomics 74 2011 567 576
102. J. Malmstrom, M. Beck, and A. Schmidt Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans Nature 460 2009 762 765
103. P. Francois, A. Scherl, D. Hochstrasser, and J. Schrenzel Proteomic approaches to study Staphylococcus aureus pathogenesis J Proteomics 73 2010 701 708
104. J.C. Lindon, E. Holmes, and J.K. Nicholson Metabonomics in pharmaceutical R&D Febs J 274 2007 1140 1151
105. J.K. Nicholson, I.D. Wilson, and J.C. Lindon Pharmacometabonomics as an effector for personalized medicine Pharmacogenomics 12 2011 103 111
106. M.J. van der Werf, R.H. Jellema, and T. Hankemeier Microbial metabolomics: replacing trial-and-error by the unbiased selection and ranking of targets J Ind Microbiol Biotechnol 32 2005 234 252
107. N. Vinayavekhin, E.A. Homan, and A. Saghatelian Exploring disease through metabolomics ACS Chem Biol 5 2010 91 103
108. J.P. Henderson, J.R. Crowley, and J.S. Pinkner Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli PLoS Pathog 5 2009 e1000305
109. J. Munger, B.D. Bennett, and A. Parikh Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy Nat Biotechnol 26 2008 1179 1186
110. K.F. Aoki-Kinoshita An introduction to bioinformatics for glycomics research PLoS Comput Biol 4 2008 e1000075
111. M.R. Wenk The emerging field of lipidomics Nat Rev Drug Discov 4 2005 594 610
112. M.R. Wenk Lipidomics: new tools and applications Cell 143 2010 888 895
113. M.R. Wenk Lipidomics of host-pathogen interactions FEBS Lett 580 2006 5541 5551
114. S. Srivastava Move over proteomics, here comes glycomics J Proteome Res 7 2008 1799
115. G.W. Hart, and R.J. Copeland Glycomics hits the big time Cell 143 2010 672 676
116. S. Hameed, S. Dhamgaye, A. Singh, S.K. Goswami, and R. Prasad Calcineurin signaling and membrane lipid homeostasis regulates iron mediated multidrug resistance mechanisms in Candida albicans PLoS One 6 2011 e18684
117. B. Brugger, B. Glass, and P. Haberkant The HIV lipidome: a raft with an unusual composition Proc Natl Acad Sci U S A 103 2006 2641 2646
118. B. Brugger, E. Krautkramer, and N. Tibroni Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains Retrovirology 4 2007 70
119. S.T. Liu, R. Sharon-Friling, and P. Ivanova Synaptic vesicle-like lipidome of human cytomegalovirus virions reveals a role for SNARE machinery in virion egress Proc Natl Acad Sci U S A 108 2011 12869 12874
120. D.L. Diamond, A.J. Syder, and J.M. Jacobs Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics PLoS Pathog 6 2010 e1000719
121. A. Merz, G. Long, and M.S. Hiet Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome J Biol Chem 286 2011 3018 3032
122. Y.P. van der Meer-Janssen, J. van Galen, J.J. Batenburg, and J.B. Helms Lipids in host-pathogen interactions: pathogens exploit the complexity of the host cell lipidome Prog Lipid Res 49 2010 1 26
123. X. Song, H. Yu, and X. Chen A sialylated glycan microarray reveals novel interactions of modified sialic acids with proteins and viruses J Biol Chem 286 2011 31610 31622
124. X. Yu, B.S. Coulson, and F.E. Fleming Novel structural insights into rotavirus recognition of ganglioside glycan receptors J Mol Biol 413 2011 929 939
125. R. Toman, L. Skultety, and R. Ihnatko Coxiella burnetii glycomics and proteomics-tools for linking structure to function Ann N Y Acad Sci 1166 2009 67 78
126. L. Krishnamoorthy, J.W. Bess Jr., A.B. Preston, K. Nagashima, and L.K. Mahal HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin Nat Chem Biol 5 2009 244 250
127. Bhak J. History of omics. Available from: http://omics.org. Accessed September 28, 2011.
128. E.S. Lander, L.M. Linton, and B. Birren Initial sequencing and analysis of the human genome Nature 409 2001 860 921
129. J.C. Venter, M.D. Adams, and E.W. Myers The sequence of the human genome Science 291 2001 1304 1351
130. D.A. Relman, and S. Falkow The meaning and impact of the human genome sequence for microbiology Trends Microbiol 9 2001 206 208
131. D.A. Relman New technologies, human-microbe interactions, and the search for previously unrecognized pathogens J Infect Dis 186 2002 S254 S258
132. L.V. Hooper, and J.I. Gordon Commensal host-bacterial relationships in the gut Science 292 2001 1115 1118
133. P.B. Eckburg, E.M. Bik, and C.N. Bernstein Diversity of the human intestinal microbial flora Science 308 2005 1635 1638
134. National Institutes of Health NIH launches human microbiome project 2007 National Institutes of Health Bethesda, MD
135. National Institutes of Health Human microbiome project 2007 National Institutes of Health Bethesda, MD
136. J. Peterson, S. Garges, and M. Giovanni The NIH human microbiome project Genome Res 19 2009 2317 2323
137. Z. Gao, C.H. Tseng, B.E. Strober, Z. Pei, and M.J. Blaser Substantial alterations of the cutaneous bacterial biota in psoriatic lesions PLoS One 3 2008 e2719
138. D.E. Nelson, B. Van Der Pol, and Q. Dong Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection PLoS One 5 2010 e14116
139. D.N. Frank, C.E. Robertson, and C.M. Hamm Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases Inflamm Bowel Dis 17 2011 179 184
140. L. Yang, X. Lu, and C.W. Nossa Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome Gastroenterology 137 2009 588 597
141. T. Ichinohe, I.K. Pang, and Y. Kumamoto Microbiota regulates immune defense against respiratory tract influenza A virus infection Proc Natl Acad Sci U S A 108 2011 5354 5359
142. B. Langmead, M.C. Schatz, J. Lin, M. Pop, and S.L. Salzberg Searching for SNPs with cloud computing Genome Biol 10 2009 R134
143. J.G. Caporaso, J. Kuczynski, and J. Stombaugh QIIME allows analysis of high-throughput community sequencing data Nat Methods 7 2010 335 336
144. G. Storch, G. Weinstock, and E. Sodergren The human virome in children and its relationship to febrile illness Human Microbiome Project 2010
145. D. Willner, M. Furlan, and M. Haynes Metagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals PLoS One 4 2009 e7370
146. S. Minot, R. Sinha, J. Chen, and H. Li The human gut virome: inter-individual variation and dynamic response to diet Genome Res 21 2011 1616 1625
147. M.A. Ghannoum, R.J. Jurevic, and P.K. Mukherjee Characterization of the oral fungal microbiome (mycobiome) in healthy individuals PLoS Pathog 6 2010 e1000713
148. S.H. Huang, T. Triche, and A.Y. Jong Infectomics: genomics and proteomics of microbial infections Funct Integr Genomics 1 2002 331 344
149. K.I. Goh, M.E. Cusick, and D. Valle The human disease network Proc Natl Acad Sci U S A 104 2007 8685 8690
150. V. Navratil, B. de Chassey, C.R. Combe, and V. Lotteau When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases BMC Syst Biol 5 2011 13
151. A. Aderem, J.N. Adkins, and C. Ansong A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm MBio 2 2011 e00325-10
152. M.H. Haverkamp, J.T. van Dissel, and S.M. Holland Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling Microbes Infect 8 2006 1157 1166
153. B.L. Kidder, G. Hu, and K. Zhao ChIP-Seq: technical considerations for obtaining high-quality data Nat Immunol 12 2011 918 922
154. National Institute of Allergy and Infectious Disease TB systems biology program 2011 NIAID Bethesda, Md
155. National Institute of Allergy and Infectious Disease Systems virology 2011 NIAID Bethesda, Md
156. National Institute of Allergy and Infectious Disease Systems influenza 2011 NIAID Bethesda, Md
157. B. Zhang, and S. Horvath A general framework for weighted gene co-expression network analysis Stat Appl Genet Mol Biol 4 2005 17
158. C. Li, A. Bankhead 3rd, and A.J. Eisfeld Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus J Virol 85 2011 10955 10967
159. B.G. Bradel-Tretheway, Z. Kelley, and S. Chakraborty-Sett The human H5N1 influenza A virus polymerase complex is active in vitro over a broad range of temperatures, in contrast to the WSN complex, and this property can be attributed to the PB2 subunit J Gen Virol 89 2008 2923 2932
160. X. Peng, L. Gralinski, and C.D. Armour Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling MBio 1 2010 e00206 e00210
161. National Institute of Allergy and Infectious Disease Center for Systems Biology of EnteroPathogens 2011 NIAID Bethesda, Md Available from: http://www.sysbep.org Accessed September 28, 2011
162. J. Schellenberger, R. Que, and R.M. Fleming Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0 Nat Protoc 6 2011 1290 1307
163. S.A. Becker, A.M. Feist, and M.L. Mo Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox Nat Protoc 2 2007 727 738
164. H. Yoon, C. Ansong, and J.E. McDermott Systems analysis of multiple regulator perturbations allows discovery of virulence factors in Salmonella BMC Syst Biol 5 2011 100
165. G.W. Buchko, G. Niemann, and E.S. Baker A multi-pronged search for a common structural motif in the secretion signal of Salmonella enterica serovar Typhimurium type III effector proteins Mol Biosyst 6 2010 2448 2458
166. R. Germain Ron Germain: towards a grand unified theory. Interview by Amy Maxmen J Exp Med 207 2010 266 267
167. National Institute of Allergy and Infectious Disease Laboratory of Systems Biology (LSB) 2011 NIAID Bethesda, Md Available from: http://www.niaid.nih.gov/labsandresources/labs/aboutlabs/lsb/pages/default.aspx? wt.ac=bcLsb Accessed September 30, 2011
168. J.J. Miles, A.M. Bulek, and D.K. Cole Genetic and structural basis for selection of a ubiquitous T cell receptor deployed in Epstein-Barr virus infection PLoS pathogens 6 2010 e1001198
169. L. Yang, J. Zhang, B. Ho, and J.L. Ding Histidine-mediated pH-sensitive regulation of M-ficolin:GlcNAc binding activity in innate immunity examined by molecular dynamics simulations PLoS One 6 2011 e19647
170. N. Rapin, O. Lund, M. Bernaschi, and F. Castiglione Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system PLoS One 5 2010 e9862
171. F. Mitha, T.A. Lucas, F. Feng, T.B. Kepler, and C. Chan The multiscale systems immunology project: software for cell-based immunological simulation Source Code Biol Med 3 2008 6
172. B. Pulendran Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology Nat Rev Immunol 9 2009 741 747
173. T.D. Querec, R.S. Akondy, and E.K. Lee Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans Nat Immunol 10 2009 116 125
174. H.I. Nakaya, J. Wrammert, and E.K. Lee Systems biology of vaccination for seasonal influenza in humans Nat Immunol 12 2011 786 795
175. R. Santamaria, L. Rizzetto, and M. Bromley Systems biology of infectious diseases: a focus on fungal infections Immunobiology 216 2011 1212 1227
176. L. Liang, X. Tan, and S. Juarez Systems biology approach predicts antibody signature associated with Brucella melitensis infection in humans J Proteome Res 10 2011 4813 4824
177. L.G. Adams, S. Khare, and S.D. Lawhon Enhancing the role of veterinary vaccines reducing zoonotic diseases of humans: linking systems biology with vaccine development Vaccine 29 2011 7197 7206
178. R. Rappuoli, S. Black, and P.H. Lambert Vaccine discovery and translation of new vaccine technology Lancet 378 2011 360 368
179. B. Pulendran, S. Li, and H.I. Nakaya Systems vaccinology Immunity 33 2010 516 529
180. G.P. Smith Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 228 1985 1315 1317
181. L.F. Wang, and M. Yu Epitope identification and discovery using phage display libraries: applications in vaccine development and diagnostics Curr Drug Targets 5 2004 1 15
182. S. Khurana, J. Wu, and N. Verma H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans J Virol 85 2011 10945 10954
183. C.F. Barbas 3rd, A.S. Kang, R.A. Lerner, and S.J. Benkovic Assembly of combinatorial antibody libraries on phage surfaces: the gene III site Proc Natl Acad Sci U S A 88 1991 7978 7982
184. L. Sun, X. Lu, and C. Li Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses PLoS One 4 2009 e5476
185. A.L. Nelson, E. Dhimolea, and J.M. Reichert Development trends for human monoclonal antibody therapeutics Nat Rev Drug Discov 9 2010 767 774
186. T.S. Migone, G.M. Subramanian, and J. Zhong Raxibacumab for the treatment of inhalational anthrax N Engl J Med 361 2009 135 144
187. W.R. Galloway, A. Bender, M. Welch, and D.R. Spring The discovery of antibacterial agents using diversity-oriented synthesis Chem Commun (Camb) 2009 2446 2462
188. T. Bratkovic Progress in phage display: evolution of the technique and its applications Cell Mol Life Sci 67 2010 749 767
189. D.A. Pereira, and J.A. Williams Origin and evolution of high throughput screening Br J Pharmacol 152 2007 53 61
190. J.J. Agresti, E. Antipov, and A.R. Abate Ultrahigh-throughput screening in drop-based microfluidics for directed evolution Proc Natl Acad Sci U S A 107 2010 4004 4009
191. T. Perrior Overcoming bottlenecks in drug discovery Drug Discov World 2010 29 33
192. F.S. Collins The Genome Project and human health FASEB J 5 1991 77
193. R.L. Schilsky Personalized medicine in oncology: the future is now Nat Rev Drug Discov 9 2010 363 366
194. M. Cronin, and J.S. Ross Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology Biomark Med 5 2011 293 305
195. T.I. Sorensen, G.G. Nielsen, P.K. Andersen, and T.W. Teasdale Genetic and environmental influences on premature death in adult adoptees N Engl J Med 318 1988 727 732
196. J.L. Casanova, L. Abel, and L. Quintana-Murci Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics Annu Rev Immunol 29 2011 447 491
197. Y. Guo, M. Audry, and M. Ciancanelli Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity J Exp Med 208 2011 2083 2098
198. C. Picard, J.L. Casanova, and A. Puel Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency Clin Microbiol Rev 24 2011 490 497
199. P. Tabarsi, M. Marjani, and N. Mansouri Lethal tuberculosis in a previously healthy adult with IL-12 receptor deficiency J Clin Immunol 31 2011 537 539
200. P.D. Burbelo, S.K. Browne, and E.P. Sampaio Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia Blood 116 2010 4848 4858
201. S.M. Holland Interferon gamma, IL-12, IL-12R and STAT-1 immunodeficiency diseases: disorders of the interface of innate and adaptive immunity Immunol Res 38 2007 342 346
202. D.C. Vinh, B. Schwartz, and A.P. Hsu Interleukin-12 receptor beta1 deficiency predisposing to disseminated Coccidioidomycosis Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 52 2011 e99 e102
203. S.M. Holland, F.R. DeLeo, and H.Z. Elloumi STAT3 mutations in the hyper-IgE syndrome N Engl J Med 357 2007 1608 1619
204. International HapMap Consortium A haplotype map of the human genome Nature 437 2005 1299 1320
205. F.O. Vannberg, S.J. Chapman, and A.V. Hill Human genetic susceptibility to intracellular pathogens Immunol Rev 240 2011 105 116
206. N.O. Oki, A.A. Motsinger-Reif, and P.R. Antas Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study BMC Res Notes 4 2011 28
207. A. Rauch, Z. Kutalik, and P. Descombes Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study Gastroenterology 138 2010 1338 1345 45 e1-7
208. D.L. Thomas, C.L. Thio, and M.P. Martin Genetic variation in IL28B and spontaneous clearance of hepatitis C virus Nature 461 2009 798 801
209. A. Poustka, T. Pohl, and D.P. Barlow Molecular approaches to mammalian genetics Cold Spring Harb Symp Quant Biol 51 1986 131 139
210. C.R. Cantor, A. Mirzabekov, and E. Southern Report on the sequencing by hybridization workshop Genomics 13 1992 1378 1383
211. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
212. R.A. Lempicki, M.A. Polis, and J. Yang Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons J Infect Dis 193 2006 1172 1177
213. M. Jacobsen, D. Repsilber, and A. Gutschmidt Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis J Mol Med (Berl) 85 2007 613 621
214. R. Reghunathan, M. Jayapal, and L.Y. Hsu Expression profile of immune response genes in patients with severe acute respiratory syndrome BMC Immunol 6 2005 2
215. C.P. Simmons, S. Popper, and C. Dolocek Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever J Infect Dis 195 2007 1097 1107
216. A.K. Zaas, M. Chen, and J. Varkey Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans Cell Host Microbe 6 2009 207 217
217. M.I. Ardura, R. Banchereau, and A. Mejias Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections PLoS One 4 2009 e5446
218. L.J. Thompson, S.J. Dunstan, and C. Dolecek Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi Proc Natl Acad Sci U S A 106 2009 22433 22438
219. S. Hetherington, S. McGuirk, and G. Powell Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir Clin Ther 23 2001 1603 1614
220. S. Mallal, E. Phillips, and G. Carosi HLA-B5701 screening for hypersensitivity to abacavir N Engl J Med 358 2008 568 579
221. M. Genebat, E. Ruiz-Mateos, and J.A. Leon Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients J Antimicrob Chemother 64 2009 845 849
222. N.F. Marko, and R.J. Weil Mathematical modeling of molecular data in translational medicine: theoretical considerations Sci Transl Med 2 2010 56rv4
223. P. Royston, D.G. Altman, and W. Sauerbrei Dichotomizing continuous predictors in multiple regression: a bad idea Stat Med 25 2006 127 141
224. R.C. MacCallum, S. Zhang, K.J. Preacher, and D.D. Rucker On the practice of dichotomization of quantitative variables Psychol Methods 7 2002 19 40
225. X. Zhao, and L.W. Cheung Kernel-imbedded Gaussian processes for disease classification using microarray gene expression data BMC Bioinformatics 8 2007 67
226. W. Kong, C.R. Vanderburg, H. Gunshin, J.T. Rogers, and X. Huang A review of independent component analysis application to microarray gene expression data BioTechniques 45 2008 501 520
227. G.F. Lawler Introduction to stochastic processes 2nd ed. 2006 CRC Boca Raton, FL
228. Q. Yan Translational bioinformatics and systems biology approaches for personalized medicine Methods Mol Biol 662 2010 167 178
229. M. Kanehisa, S. Goto, Y. Sato, M. Furumichi, and M. Tanabe KEGG for integration and interpretation of large-scale molecular data sets Nucleic Acids Res 40 2011 D109 D114
230. I.N. Sarkar, A.J. Butte, Y.A. Lussier, P. Tarczy-Hornoch, and L. Ohno-Machado Translational bioinformatics: linking knowledge across biological and clinical realms J Am Med Inform Assoc 18 2011 354 357
231. [No authors listed] Raising the game Nat Biotechnol 26 2008 137
232. S.M. Paul, D.S. Mytelka, and C.T. Dunwiddie How to improve R&D productivity: the pharmaceutical industry's grand challenge Nat Rev Drug Discov 9 2010 203 214
233. US Food and Drug Administration NME drug and new biologic approvals 2011 FDA Silver Spring, Md
234. M. Goodman Market watch: pharma industry strategic performance: 2007-2012E Nat Rev Drug Discov 7 2008 967
235. B. Munos Lessons from 60 years of pharmaceutical innovation Nat Rev Drug Discov 8 2009 959 968
236. F.R. Lichtenberg The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001 Int J Health Care Finance Econ 5 2005 47 73
237. H. Ledford Translational research: 4 ways to fix the clinical trial Nature 477 2011 526 528
238. National Institutes of Health Regulatory science 2011 NIH Bethesda, Md
239. US Food and Drug Administration FDA-NIH Joint Leadership Council Charter 2011 FDA Silver Spring, Md
240. US Food and Drug Administration NIoH FDA-NIH News Release: NIH and FDA announce collaborative initiative to fast-track innovations to the public 2010 FDA Silver Spring, Md
241. F.S. Collins, G.M. Gray, and J.R. Bucher Toxicology. Transforming environmental health protection Science 319 2008 906 907
242. D. Kennedy FDA centennial Science 312 2006 19
243. A.J. Wood A proposal for radical changes in the drug-approval process N Engl J Med 355 2006 618 623
244. F.S. Collins Mining for therapeutic gold Nat Rev Drug Discov 10 2011 397
245. F.C. Fang, and A. Casadevall Lost in translation-basic science in the era of translational research Infect Immun 78 2010 563 566
246. G.A. Petsko Herding CATS Sci Transl Med 3 2011 97cm24
247. C.S. Redhead, and P.W. Smith Public Health Service (PHS) Agencies: Overview and Funding, FY2010-FY2012 2011 Congressional Research Service Washington, DC
248. Smrb Hears From The Public About Ncats. Available from: http://feedback.nih.gov/index.php/ncats/smrb-hears-from-the-public-about-ncats/. Accessed March 1, 2011.
249. J. Kaiser NIH reorganization draws scrutiny from Congress Science Insider January 27, 2011
250. G.A. FitzGerald NCATS purrs: emerging signs of form and function Sci Transl Med 3 2011 83ed2